Atria Investments’s NEVRO CORP. NVRO Stock Holding History

Atria Investments’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,993	Closed	-$299K	–	783
2020 Q1	$299K	Sell	2,993 -1,017	-25%	-$122K	0.02%	444
2019 Q4	$471K	Buy	4,010 +79	+2%	+$7.82K	0.01%	811
2019 Q3	$338K	Buy	3,931 +810	+26%	+$61.3K	0.01%	683
2019 Q2	$250K	Buy	+3,121	New	+$194K	0.01%	809

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Atria Investments's NVRO Position: Q2 2020 in Review

Atria Investments sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 2,993 shares — an estimated $299K sold.

Atria Investments first reported a position in NVRO in Q2 2019 and held it in 4 quarters. The position peaked at $471K in Q4 2019. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

Atria Investments reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
Atria Investments sold 2,993 NEVRO CORP. shares in Q2 2020, an estimated $299K.
Atria Investments first reported a position in NEVRO CORP. in Q2 2019 and held it in 4 quarters.
Atria Investments's NEVRO CORP. position peaked at $471K in Q4 2019.
202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.